Home›Companies›Biotech & Pharma›Candor Therapeutics

Candor Therapeutics Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Aug 28, 2026·Suggest an edit

About Candor Therapeutics

Candor Therapeutics is a private company based in Sunnyvale, California, incorporated in 2026 in Delaware. It has reported $50,000 raised in one offering on Form D since August 2026. Its chief executive is Ramkumar Mandalam.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 17, 2026Aug 28, 2026$50,000of $750K target2$25,000Simple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Candor Therapeutics's Form D filed Aug 28, 2026.

RM
Ramkumar Mandalam
Chief Executive Officer and director

Sources

  1. SECCandor Therapeutics Inc. filing history